Capecitabine (NX) Versus Docetaxel Plus Capecitabine (TX) as 1-line Chemotherapy on Metastatic Breast Cancer (MBC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01126138
Recruitment Status : Unknown
Verified May 2010 by Chinese Academy of Medical Sciences.
Recruitment status was:  Recruiting
First Posted : May 19, 2010
Last Update Posted : May 4, 2011
Hoffmann-La Roche
Information provided by:
Chinese Academy of Medical Sciences

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : May 2015
  Estimated Study Completion Date : August 2015
Publications of Results:
Other Publications: